These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32967340)

  • 1. Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
    Parada-Turska J; Wójcicka G; Beltowski J
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
    Rusek M; Pastryk JE; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
    Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
    Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
    Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
    FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.
    Borowczyk K; Shih DM; Jakubowski H
    J Alzheimers Dis; 2012; 30(2):225-31. PubMed ID: 22406444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.
    Jamroz-Wiśniewska A; Bełtowski J; Wójcicka G; Bartosik-Psujek H; Rejdak K
    Oxid Med Cell Longev; 2020; 2020():1654754. PubMed ID: 32256946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
    Pastryk JE; Rusek M; Bełtowski J
    Chem Biol Interact; 2016 Nov; 259(Pt B):407-412. PubMed ID: 27378623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Jamroz-Wiśniewska A; Bełtowski J; Bartosik-Psujek H; Wójcicka G; Rejdak K
    Int J Neurosci; 2017 Aug; 127(8):709-715. PubMed ID: 27671515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.
    Beltowski J; Wójcicka G; Jakubowski H
    J Endocrinol; 2010 Feb; 204(2):191-8. PubMed ID: 19887391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein N-homocysteinylation: implications for atherosclerosis.
    Jakubowski H
    Biomed Pharmacother; 2001 Oct; 55(8):443-7. PubMed ID: 11686577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
    Jakubowski H
    Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.
    Yilmaz N
    Arch Med Sci; 2012 Feb; 8(1):138-53. PubMed ID: 22457688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments.
    Moshtaghie E; Nayeri H; Moshtaghie AA; Asgary S
    ARYA Atheroscler; 2022 Mar; 18(2):1-6. PubMed ID: 36819838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.